Skip to main content
. 2013 Dec 6;18(12):15035–15050. doi: 10.3390/molecules181215035

Figure 6.

Quantitative analysis of the thiazacridine and imidazacridine derivatives effects on the relaxation of pUC19 DNA plasmid by human topoisomerase 1.

Figure 6

Lane 1, DNA pUC19 and lane 2, topo 1 + DNA pUC19 (controls). Lanes 3–6, topo 1 + DNA pUC19 + compounds 47 (50 µM), respectively; lanes 7–10, topo 1 + DNA pUC19 + compounds 47 (100 µM), respectively, and lanes 11–14, topo 1 + DNA pUC19 + compounds 47 (200 µM), respectively.